Recent review articles about lung cancer (InTextoResearch)

Recent review articles about lung cancer (InTextoResearch)


InTextoResearch, agency for scientific information

InTextoResearch informs on the most recent review articles about lung
cancer:

Inflammation in the development of lung cancer: epidemiological
evidence.
Engels EA.
Expert Rev Anticancer Ther. 2008 Apr;8(4):605-15.

Epidermal growth factor receptor (EGFR) targeted therapies in non-
small cell lung cancer (NSCLC).
Metro G, Finocchiaro G, Toschi L, Bartolini S, Magrini E, Cancellieri
A, Trisolini R, Castaldini L, Tallini G, Crino L, Cappuzzo F.
Rev Recent Clin Trials. 2006 Jan;1(1):1-13.

A critical appraisal of overdiagnosis: estimates of its magnitude and
implications for lung cancer screening.
Reich JM.
Thorax. 2008 Apr;63(4):377-83.

Vinflunine: clinical perspectives of an emerging anticancer agent.
Yun-San Yip A, Yuen-Yuen Ong E, Chow LW.
Expert Opin Investig Drugs. 2008 Apr;17(4):583-91.

EGFR antagonists in cancer treatment.
Ciardiello F, Tortora G.
N Engl J Med. 2008 Mar 13;358(11):1160-74.

Usefulness of contrast-enhanced magnetic resonance imaging for
evaluating solitary pulmonary nodules.
Fujimoto K.
Cancer Imaging. 2008 Mar 3;8:36-44.

Advances in the molecular biology of malignant mesothelioma.
Toyooka S, Kishimoto T, Date H.
Acta Med Okayama. 2008 Feb;62(1):1-7.

Systemic treatment for advanced (stage IIIb/IV) non-small cell lung
cancer: more treatment options; more things to consider. Conclusion.
Bunn PA Jr, Thatcher N.
Oncologist. 2008;13 Suppl 1:37-46.

Considerations for second-line therapy of non-small cell lung cancer.
Stinchcombe TE, Socinski MA.
Oncologist. 2008;13 Suppl 1:28-36.

Local control of regional and metastatic lesions and indication for
systemic chemotherapy in patients with non-small cell lung cancer.
Sekine I, Sumi M, Saijo N.
Oncologist. 2008;13 Suppl 1:21-7.

Clinical evidence for second- and third-line treatment options in
advanced non-small cell lung cancer.
de Marinis F, Grossi F.
Oncologist. 2008;13 Suppl 1:14-20.

Systemic chemotherapy for advanced non-small cell lung cancer: recent
advances and future directions.
Ramalingam S, Belani C.
Oncologist. 2008;13 Suppl 1:5-13.

Small cell lung cancer.
Sher T, Dy GK, Adjei AA.
Mayo Clin Proc. 2008 Mar;83(3):355-67.

The potential role of mTOR inhibitors in non-small cell lung cancer
Gridelli C, Maione P, Rossi A.
Oncologist. 2008 Feb;13(2):139-47.

Epidermal growth factor receptor inhibitors in the treatment of lung
cancer: reality and hopes.
Wheatley-Price P, Shepherd FA.
Curr Opin Oncol. 2008 Mar;20(2):162-75.

Neuroendocrine tumors of the lung.
García-Yuste M, Matilla JM, González-Aragoneses F.
Curr Opin Oncol. 2008 Mar;20(2):148-54.

Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a
literature-based systematic HuGE review and meta-analysis.
Carlsten C, Sagoo GS, Frodsham AJ, Burke W, Higgins JP.
Am J Epidemiol. 2008 Apr 1;167(7):759-74.

Genetic similarities between organogenesis and tumorigenesis of the
lung.
Powers S, Mu D.
Cell Cycle. 2008 Jan;7(2):200-4.

Gene delivery for lung cancer using nonviral gene vectors.
Wang JT, Peng DY, Chen M, Ye JS.
Pharmazie. 2007 Oct;62(10):723-6.

Type I pleuropulmonary blastoma: pathology and biology study of 51
cases from the international pleuropulmonary blastoma registry.
Hill DA, Jarzembowski JA, Priest JR, Williams G, Schoettler P, Dehner
LP.
Am J Surg Pathol. 2008 Feb;32(2):282-95.


(contact at InTextoResearch: Marc Lacroix, Baelen, Wallonia, Belgium -
scimedweb@mail,com )